FDA NDC Directory · JSON-LD · Markdown

Liothyronine Sodium

NDC 39822-0151 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Labeler / ManufacturerXGen Pharmaceuticals DJB, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA076923
Dosage form / routeINJECTION, SOLUTION · INTRAVENOUS
Active ingredientsLIOTHYRONINE SODIUM (10 ug/mL)
Marketing started20050817
Package count1

External sources

Source: openFDA. Public-domain (CC0).